New shot tested to block deadly tetanus infection
NCT ID NCT05625477
Summary
This study tested a new antibody injection called TNM002 to see if it could help prevent tetanus, a serious bacterial infection. Researchers compared it to the standard protective shot (human tetanus immunoglobulin) and a placebo in 240 healthy Chinese adults. The main goal was to see if TNM002 raised protective antibody levels as well as or better than the standard shot and to check its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PKUCare Luzhong Hospital
Zibo, Shandong, China
-
The First Affiliated Hospital of Shantou University Medical College
Shantou, Guangdong, China
-
Wuxi People's Hospital
Wuxi, Jiangsu, China
-
Yunnan Provincial Hospital of Traditional Chinese Medicine
Kunming, Yunnan, China
Conditions
Explore the condition pages connected to this study.